Patricia A Olofsen

8PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersHaematological tumoursTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 11, 2025
Quantification of Signal Transduction Pathway Activity in Pancreatic Ductal Adenocarcinoma.

Léon Raymakers, Lois A Daamen, Martijn P W Intven

|Oct 07, 2025
Germ line LCP1 mutations cause immunodeficiency with neutropenia, monocytopenia, lymphopenia, and defective cytokinesis.

Thijs van Bergen, Dennis A Bosch, Christine Bellanné-Chantelot

|May 13, 2025
The Efficacy of Targeted Monoclonal IgA Antibodies Against Pancreatic Ductal Adenocarcinoma.

Léon Raymakers, Elsemieke M Passchier, Meggy E L Verdonschot

|Jul 03, 2024
Enhancing Neutrophil Cytotoxicity of a Panel of Clinical EGFR Antibodies by Fc Engineering to IgA3.0.

Chilam Chan, J H Marco Jansen, Ilona S T Hendriks

|Aug 11, 2023
The Role of Cytokines in Neutrophil Development, Tissue Homing, Function and Plasticity in Health and Disease.

Maria Tsioumpekou, Daniëlle Krijgsman, Jeanette H W Leusen

|Jun 20, 2023
Characterization of human Fc alpha receptor transgenic mice: comparison of CD89 expression and antibody-dependent tumor killing between mouse strains.

Marjolein C Stip, J H Marco Jansen, Maaike Nederend

Pageof 2